We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPL
51
PPL Corp
PPL
$27.3B
$3.7M 0.47%
103,144
+6,536
+7% +$219K
BA icon
52
Boeing
BA
$175B
$3.67M 0.47%
11,255
+1,403
+14% +$497K
BMY icon
53
Bristol-Myers Squibb
BMY
$130B
$3.58M 0.45%
55,739
+35,111
+170% +$2.01M
PYPL icon
54
PayPal
PYPL
$51.7B
$3.53M 0.45%
32,624
-210
-0.6% -$21.9K
TFC icon
55
Truist Financial
TFC
$64.6B
$3.53M 0.45%
62,601
+13,025
+26% +$705K
DIS icon
56
Walt Disney
DIS
$171B
$3.51M 0.45%
24,262
+341
+1% +$47.6K
SRE icon
57
Sempra
SRE
$59.5B
$3.48M 0.44%
45,950
+1,936
+4% +$142K
UNH icon
58
UnitedHealth
UNH
$391B
$3.37M 0.43%
11,453
+1,344
+13% +$352K
CMCSA icon
59
Comcast
CMCSA
$85.3B
$3.36M 0.43%
74,612
+3,895
+6% +$173K
CCI icon
60
Crown Castle
CCI
$33.1B
$3.27M 0.42%
22,979
+679
+3% +$92.6K
AVGO icon
61
Broadcom
AVGO
$1.83T
$3.24M 0.41%
102,450
+3,590
+4% +$109K
ENB icon
62
Enbridge
ENB
$121B
$3.15M 0.4%
79,294
+3,592
+5% +$134K
ETN icon
63
Eaton
ETN
$150B
$3.12M 0.4%
32,892
+13,341
+68% +$1.18M
CRM icon
64
Salesforce
CRM
$149B
$3.06M 0.39%
18,815
+565
+3% +$88.6K
PAYX icon
65
Paychex
PAYX
$42.2B
$3.04M 0.39%
35,684
-1,143
-3% -$96.4K
PFF icon
66
iShares Preferred and Income Securities ETF
PFF
$13.2B
$3.01M 0.38%
80,075
-997
-1% -$37.2K
AEP icon
67
American Electric Power
AEP
$72.7B
$2.97M 0.38%
31,457
+710
+2% +$65.6K
MDLZ icon
68
Mondelez International
MDLZ
$80B
$2.89M 0.37%
52,413
+5,868
+13% +$314K
USB icon
69
US Bancorp
USB
$100B
$2.68M 0.34%
45,151
+1,254
+3% +$72.5K
AZN icon
70
AstraZeneca
AZN
$268B
$2.6M 0.33%
26,119
+385
+1% +$36.2K
TRI icon
71
Thomson Reuters
TRI
$45B
$2.49M 0.32%
32,988
+292
+0.9% +$21.3K
IWO icon
72
iShares Russell 2000 Growth ETF
IWO
$14.3B
$2.43M 0.31%
11,340
+431
+4% +$87.5K
WMT icon
73
Walmart Inc
WMT
$901B
$2.41M 0.31%
60,933
+1,713
+3% +$68K
ADI icon
74
Analog Devices
ADI
$180B
$2.41M 0.31%
20,302
+444
+2% +$50K
NKE icon
75
Nike
NKE
$63.6B
$2.35M 0.3%
23,194
+1,328
+6% +$125K

Similar funds

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.